News
SMLR
27.00
+1.81%
0.48
Semler Scientific: Not Perfect But Worth Considering
Semler Scientific, Inc. (SMLR) has a competitive product in the cardiovascular diagnostic space. The company is awaiting a 510(k) clearance for QuantaFlo, a non-invasive vascular testing product. 73% of the company's asset base consists of cash alone. The stock has lost 4% of its value in the last six months. SMLR's valuation is cheap and buyback momentum is likely to step up.
Seeking Alpha · 4d ago
Weekly Report: what happened at SMLR last week (0422-0426)?
Weekly Report · 5d ago
Weekly Report: what happened at SMLR last week (0415-0419)?
Weekly Report · 04/22 09:50
Weekly Report: what happened at SMLR last week (0408-0412)?
Weekly Report · 04/15 09:46
Weekly Report: what happened at SMLR last week (0401-0405)?
Weekly Report · 04/08 09:48
Weekly Report: what happened at SMLR last week (0325-0329)?
Weekly Report · 04/01 09:48
Weekly Report: what happened at SMLR last week (0318-0322)?
Weekly Report · 03/25 09:49
Weekly Report: what happened at SMLR last week (0311-0315)?
Weekly Report · 03/18 09:48
Weekly Report: what happened at SMLR last week (0304-0308)?
Weekly Report · 03/11 09:47
Analysts’ Top Healthcare Picks: Semler Scientific (SMLR), Silk Road Medical (SILK)
TipRanks · 03/06 14:02
SMLR Stock Earnings: Semler Scientific Misses EPS, Beats Revenue for Q4 2023
Semler Scientific reported earnings per share of 55 cents. The company reported revenue of $15.06 million. This was 3.83% better than the analyst estimate of $14.50 million. Semler Scientific was down 2.7% in after-hours trading.
Investorplace · 03/06 01:51
Semler Scientific Inc reports results for the quarter ended in December - Earnings Summary
Semler Scientific Inc reports quarterly adjusted earnings of 59 cents per share for the quarter ended in December. Revenue rose 9.1% to $15.06 million from a year ago. The company reported quarterly income of $4.22 million. Semler Scientific shares had risen by 10.3% this quarter.
Reuters · 03/05 23:27
Semler Scientific GAAP EPS of $0.55 misses by $0.02, revenue of $15.1M beats by $0.6M
Seeking Alpha · 03/05 21:03
*Semler Scientific 4Q EPS 55c >SMLR
Dow Jones · 03/05 21:01
*Semler Scientific 4Q Net $4.22M >SMLR
Dow Jones · 03/05 21:01
Press Release: Semler Scientific Reports Fourth Quarter and Full Year 2023 Financial Results
Semler Scientific reports financial results for the fourth quarter and full year ended December 31, 2023. The company reports continued growth in sales of QuantaFlo(R) for peripheral arterial disease testing. Semler Scientific is a company that develops, manufactures and markets innovative medical products.
Dow Jones · 03/05 21:01
Press Release: Semler Scientific Reports Fourth -3-
Prove to be accurate, and actual results and future events could differ from those anticipated in such statements. All forward-looking statements are qualified in their entirety. Semler Scientific reports fourth quarter and full-year results. The company's shares are trading on the Nasdaq.
Dow Jones · 03/05 21:01
*Semler Scientific 4Q Rev $15.1M >SMLR
Dow Jones · 03/05 21:01
12 Health Care Stocks Moving In Tuesday's Intraday Session
Sunshine Biopharma stock rose 142.3% to $0.11 during Tuesday's regular session. Ocean Biomedical (NASDAQ:OCEA) shares rose 54.65% to $6.31. Apogee Therapeutics shares rose 50.83% BeyondSpring shares rose 46.34% in the same session.
Benzinga · 03/05 17:33
Earnings Scheduled For March 5, 2024
Target is estimated to report quarterly earnings at $2.22 per share on revenue of $29.33 billion. Companies reporting before the bell include NIO, Target and Nordstrom. Companies expected to report earnings for their fourth quarter include Vivid Seats, V2X and NIO.
Benzinga · 03/05 10:00
More
Webull provides a variety of real-time SMLR stock news. You can receive the latest news about Semler Scientific Inc through multiple platforms. This information may help you make smarter investment decisions.
About SMLR
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.